An investigational device shown as a work-in-progress at the RSNA meeting promises to improve the detection of breast cancer by keying off the process of angiogenesis, which can transform an innocuous tumor into a lethal one by triggering the growth of new blood vessels to feed the cancer.
An investigational device shown as a work-in-progress at the RSNA meeting promises to improve the detection of breast cancer by keying off the process of angiogenesis, which can transform an innocuous tumor into a lethal one by triggering the growth of new blood vessels to feed the cancer.
The ComfortScan system being developed by Dobi Medical International uses optical technology to detect abnormal blood vessel proliferation. By producing images related to the physiology of abnormal vascularization, the device offers diagnostic information that cannot be generated by anatomically based breast imaging technologies such as mammography and ultrasound.
Unlike x-ray mammography equipment, ComfortScan does not rely on the delivery of ionizing radiation to generate images of the breast. It uses light-emitting diodes to register blood vessels.
Mammography Study: Can Stand-Alone AI Enhance Detection of Interval Breast Cancer?
August 28th 2024Identifying over 23 percent of interval breast cancers with a 96 percent sensitivity in mammography interpretation, an emerging AI software also facilitated correct localization in over 75 percent of cases involving interval breast cancer, according to new research.
Can AI Facilitate Effective Triage for Supplemental Breast MRI After Negative Mammography Screening?
July 10th 2024The AISmartDensity software facilitated a cancer detection rate (CDR) with breast MRI that was nearly four times higher than the CDR previously reported in trials involving traditional breast density assessment.